Orifarm expands headquarters following huge acquisition
Last year’s multimillion-euro deal with Takeda increased the employee count by 600 heads at pharmaceutical organization Orifarm. This, and ongoing growth plans, meant the company decided to expand its headquarters with the addition of a 6,600 square meter building.
by albert rønning-andersson, translated by daniel pedersen
It is now exactly two years since pharmaceutical organization Orifarm announced the acquisition of 110 drugs from Japanese firm Takeda for EUR 615m, a deal that was officially completed in March last year.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Orifarm ramps up growth plans following USD 703m acquisition
For subscribers
Takeda's new CEO in Denmark wants to hire more people
For subscribers
